secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K/A
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001493152-24-024548
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals files 8-K/A to correct terms of ~$13.9M private placement of preferred stock and warrants
--------------------------------------------------------------------------------

- Corrected typographical errors in terms of Series G and Series F-1 Preferred Stock and Warrants from May 20, 2024 private placements.
- Private placements expected to raise approx. $13.9M gross ($8.9M Series G, $5.0M Series F-1).
- Preferred stock convertible at $1.816/share, with 10% annual dividend; redemption beginning Dec 2024.
- Company must hold stockholder meeting by Aug 1, 2024 to seek approval for share issuance above 19.99% and increase authorized shares.
- Net proceeds to be used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224024548/0001493152-24-024548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224024548/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer